Daniel Pinschewer

Has grant

Professor at University of Basel

University of Basel
Country flag
Switzerland

Research Interests

Explore related searches

Contact this professor

LinkedIn
ORCID
Google Scholar

About

Daniel Pinschewer is a Professor at the University of Basel in Switzerland. His research primarily focuses on immunology, particularly in the areas of T cell responses and vaccination mechanisms against viral infections. Recent work includes studies on the immune responses to Orf virus-based vectors, the impact of mRNA vaccination on germinal center reactions, and the role of IL-33 in regulating immune responses in chronic infections.

Recent Grants

Grant: Close

Correlates of protective immunity to SARS-Coronavirus 2

Open Date: 2020-10-01

Close Date: 2022-09-01

Grant: Close

EVA-GLOBAL: European Virus Archive goes global

Open Date: 2020-01-01

Close Date: 2023-12-01

Grant: Close

Alarmin’ for T cell self renewal

Open Date: 2019-04-01

Close Date: 2023-03-01

Grant: Close

VacPath: Novel vaccine vectors to resist pathogen challenge

Open Date: 2019-01-01

Close Date: 2022-12-01

Grant: Close

“Immunity and tolerance in persistent viral infection”

Open Date: 2017-04-01

Close Date: 2021-09-01

Positions (1)

Publisher
source

Daniel Pinschewer

University Name
.

University of Basel

PhD students in Vaccination-Induced B Cell Immunity Against Lassa Virus

The Department of Biomedicine (DBM) at the University of Basel, in partnership with University Hospitals Basel, is a leading center for biomedical research, hosting over 67 research groups and more than 800 employees. The DBM fosters a collaborative, international environment that drives innovation and excellence in understanding health and disease. The Experimental Virology group, led by Professor Daniel Pinschewer, is recruiting two PhD students to join a project focused on vaccination-induced B cell immunity against Lassa virus (LASV). Lassa virus is endemic in West Africa and responsible for thousands of cases of fatal hemorrhagic fever annually. Despite its impact, a clinically approved vaccine is not yet available. This research aims to advance the understanding of protective memory B cell immunity, specifically how it can be elicited by genetic vaccine technologies and how it mediates protection against high-level viremia. The project leverages cutting-edge immunological and virological methods, including innovative molecular vaccine design, B cell repertoire analyses (single cell cloning and next-generation single-cell sequencing), and somatic gene therapy-based perturbation experiments in mice. The group benefits from strong extramural funding provided by the Swiss National Science Foundation (SNSF) and the European Union, as well as generous core funding and infrastructure support from the University of Basel. The research environment is enriched by the city of Basel's status as a European hotspot for infection biology, with world-class research institutions and major biopharmaceutical companies nearby. Applicants should possess basic knowledge in immunology. Prior experience in immunological or virological research and/or molecular biological approaches is advantageous. The ideal candidate will be curious, hard-working, socially skilled, and passionate about research, with eagerness to learn and a strong desire to make fundamental discoveries. Applications must include a CV, motivation letter, and names and contact details of at least two referees. To apply, submit your documents via the online recruiting tool before the deadline of July 3, 2026. For further information, consult the provided references and application link.

2 months ago

Articles (20)

Emergence and fate of stem cell–like <i>Tcf7</i> <sup>+</sup> CD8 <sup>+</sup> T cells during a primary immune response to viral infection

In response to infection, naïve CD8 + T (T N ) cells yield a large pool of short-lived terminal effector (T TE ) cells that eliminate infected host cells. In parallel, a minor population of stem cell–like central memory (T CM ) cells forms, which has the capacity to maintain immunity after pathogen clearance. It has remained uncertain whether stem-like T CM cells arise by dedifferentiation from a subset of cytolytic T TE cells or whether priming generates stem-like cells capable of seeding the T CM compartment and, if so, when cytolytic T TE cells branch off. Here, we show that CD8 + T cells with stem-like properties, which are identified by the expression of TCF1 (encoded by Tcf7 ), are present across the primary response to infection. Priming programs T N cells to undergo multiple cell divisions, over the course of which TCF1 expression is maintained. These TCF1 + cells further expand relatively independently of systemic inflammation, antigen dose, or affinity, and they quantitatively yield TCF1 + T CM cells after pathogen clearance. Inflammatory signals suppress TCF1 expression in early divided TCF1 + cells. TCF1 down-regulation is associated with the irreversible loss of self-renewal capacity and the silencing of stem/memory genes, which precedes the stable acquisition of a T TE state. TCF1 expression restrains cell cycling, explaining in part the limited expansion of TCF1 + relative to TCF1 − cells during the primary response. Thus, our data are consistent with terminal differentiation of effector cells being a step-wise process that is initiated by inflammation in primed stem-like cells, which would otherwise become central memory cells by default.

Year:

2023

Collaborators (12)

Sanjiv Luther

Full Professor

University of Lausanne

SWITZERLAND

Werner Held

University of Lausanne

SWITZERLAND

Doron Merkler

University of Geneva

SWITZERLAND

Weng Ming Ng

University of Oxford

UNITED KINGDOM

Thomas A. Bowden

University of Oxford

UNITED KINGDOM

Christoph Dehio

University of Basel

SWITZERLAND

Max Löhning

University Professor

Charité - Universitätsmedizin Berlin

GERMANY

Peter Reuther

Leibniz-Institut für Experimentelle Virologie

GERMANY

Florian Kreppel

Private Universität Witten/Herdecke gGmbH

GERMANY

Carolyn G. King

University Hospital Basel

SWITZERLAND

Katie Doores

Senior Lecturer/MRC Career Development Fellow

King’s College London

UNITED KINGDOM

Frederik Heinrich

Deutsches Rheuma-Forschungszentrum Berlin

GERMANY
Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI